These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20199954)

  • 1. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.
    Zaller ND; Yokell MA; Nayak SM; Fu JJ; Bazazi AR; Rich JD
    J Urban Health; 2012 Aug; 89(4):659-70. PubMed ID: 22427232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
    Costenbader EC; Zule WA; Coomes CC
    Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
    Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
    Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
    Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
    Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
    Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
    Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
    Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN
    J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.
    Tookes HE; Kral AH; Wenger LD; Cardenas GA; Martinez AN; Sherman RL; Pereyra M; Forrest DW; LaLota M; Metsch LR
    Drug Alcohol Depend; 2012 Jun; 123(1-3):255-9. PubMed ID: 22209091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
    Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
    BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.
    Bluthenthal RN; Kral AH; Erringer EA; Edlin BR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):505-11. PubMed ID: 9715848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.
    Cooper H; Des Jarlais D; Ross Z; Tempalski B; Bossak BH; Friedman SR
    J Urban Health; 2012 Aug; 89(4):678-96. PubMed ID: 22585448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
    Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
    Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019.
    Marotta PL; Stringer K; Beletsky L; West BS; Goddard-Eckrich D; Gilbert L; Hunt T; Wu E; El-Bassel N
    Harm Reduct J; 2021 Nov; 18(1):115. PubMed ID: 34789270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source.
    Quinn B; Chu D; Wenger L; Bluthenthal RN; Kral AH
    Int J Drug Policy; 2014 Sep; 25(5):905-10. PubMed ID: 24930425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
    Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective.
    Nacopoulos AG; Lewtas AJ; Ousterhout MM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):148-57. PubMed ID: 20199955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.